Spectrum Pharmaceuticals Company Profile (NASDAQ:SPPI)

Analyst Ratings

Consensus Ratings for Spectrum Pharmaceuticals (NASDAQ:SPPI) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $8.50 (23.73% upside)

Analysts' Ratings History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
Show:
DateFirmActionRatingPrice TargetActions
7/14/2016FBR & CoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016Jefferies GroupReiterated RatingHold$5.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2015Royal Bank Of CanadaLower Price TargetOutperform$13.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/18/2015Roth CapitalReiterated RatingNeutral$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q1($0.32)($0.14)$28.83 million$43.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415($0.18)($0.06)$33.87 million$50.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.25)($0.28)$31.87 million$28.46 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.22)($0.01)$34.48 million$44.98 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.06)($0.07)$48.00 million$38.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2015Q414($0.16)$0.09$48.50 million$51.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q314($0.17)$0.08$45.00 million$47.99 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.09)$0.09$41.50 million$46.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114($0.22)$0.01$39.49 million$40.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2014Q313($0.11)$0.05$41.96 million$41.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q3($0.07)($0.13)$38.70 million$42.44 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.12)($0.08)$33.41 million$33.23 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.32)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312$0.29$0.42$68.56 million$69.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Spectrum Pharmaceuticals (NASDAQ:SPPI)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.36)($0.21)($0.28)
Q2 20164($0.39)($0.25)($0.32)
Q3 20164($0.49)($0.26)($0.37)
Q4 20164($0.44)($0.22)($0.34)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
12/11/2012special$0.1512/18/201212/20/201212/28/2012Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Spectrum Pharmaceuticals (NASDAQ:SPPI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/5/2013Anthony E Maida IIIDirectorSell5,000$12.25$61,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012Joseph Kenneth KellerCOOBuy10,000$10.95$109,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Anthony E Maida IIIDirectorSell5,000$11.09$55,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012Anthony E Maida IIIDirectorSell5,000$12.01$60,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Spectrum Pharmaceuticals (NASDAQ:SPPI)
DateHeadline
07/30/16 05:46 PMEarnings Surprise in Focus: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Investor Newswire
07/28/16 06:48 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Cash Balance At $139.986 Millions - Stocks Daily
07/28/16 06:48 PMSpectrum Pharmaceuticals Inc. (SPPI) Jumps 5.07% on July 27 - Equities.com
07/22/16 06:22 PMEarnings Focus and Crowd Sourced Sentiment Review for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - TGP
07/22/16 06:22 PMSpectrum Pharmaceuticals Incorporated (NASDAQ:SPPI) Shorts Decreased by 5.99% After Short Covering - Consumer Eagle
07/22/16 06:22 PMSpectrum Pharmaceuticals Inc (NASDAQ:SPPI) Stock Technicals Hit Weakness - CML News
07/20/16 11:53 AMETF’s with exposure to Spectrum Pharmaceuticals, Inc. : July 20, 2016 -
07/19/16 07:31 AMEquity Roundup: Stock Performance Focus on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Press Telegraph
07/18/16 11:03 AMShare Performance Summary for: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Press Telegraph
07/17/16 05:52 PMShares Experiencing a Downtrend: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - TGP
07/14/16 06:50 PMSpectrum Pharmaceuticals Inc Realized Volatility Hits Substantially Low Level - CML News
07/14/16 10:07 AMSpectrum Settles Cancer Drug Patent Row With Fresenius
07/13/16 06:54 PMStocks inside Analysts Limelight: Exelixis, Inc. (NASDAQ:EXEL) , Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Street Updates
07/13/16 06:33 AMSpectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate injection) ANDA Patent Litigation - [at noodls] - 0455e2e0-bff7-4867-93e3-6ad5bbc9514e.pdf July 13, 2016 HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development ...
07/12/16 06:47 PMCompany Stock Focus for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI): Which Way Will Shares Head? - Press Telegraph
07/12/16 06:47 PMOption Market: Spectrum Pharmaceuticals Inc Risk Hits An Inflection Point - CML News
07/08/16 06:32 PMWall Street Ratings and Target Price Views on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Telanagana Press
07/08/16 06:32 PMBroker Outlook For Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Fiscal Standard
07/06/16 06:59 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Cash And Short-Term Investments In Stands At $139.986 - Stocks Daily
07/06/16 01:41 PMETF’s with exposure to Spectrum Pharmaceuticals, Inc. : July 6, 2016 -
07/06/16 10:37 AMStock Rating Watch and Earnings Insight for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Press Telegraph
07/06/16 10:37 AMSpectrum Pharmaceuticals Inc (NASDAQ:SPPI) Sentiment Change Report - Engelwood Daily
07/06/16 06:21 AMSpectrum Pharmaceuticals to Present Corporate Update at the Cantor Fitzgerald's 2nd Annual Healthcare Conference on July 13th - [at noodls] - 2220efda-ef63-4aca-83b8-ceab107a821b.pdf July 6, 2016 HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development ...
07/06/16 06:00 AMSpectrum Pharmaceuticals to Present Corporate Update at the Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 13th - [Business Wire] - Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at Cantor Fitzgerald’s 2nd Annual Healthcare Conference being held at the Le Parker Meridien in New York City....
07/05/16 06:12 PMShare Performance Recap for: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Press Telegraph
07/01/16 04:15 PMSPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/30/16 06:46 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Company Rating and Target Watch - Telanagana Press
06/27/16 06:25 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 06:25 PMNext Weeks Broker Price Targets For Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Fiscal Standard
06/25/16 05:55 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Current Analyst Ratings - Fiscal Standard
06/25/16 05:55 PMAnalyst's Keeping an Eye on: Spectrum Pharmaceuticals, Inc. (SPPI) - iStreetWire
06/25/16 10:11 AMAnalyst’s Keeping an Eye on: Spectrum Pharmaceuticals, Inc. (SPPI)
06/24/16 06:35 PMSpectrum Pharmaceuticals Incorporated (NASDAQ:SPPI) Sellers Covered 9.15% of Their Shorts - Engelwood Daily
06/22/16 06:29 PMFirst Week of February 2017 Options Trading For Spectrum Pharmaceuticals (SPPI)
06/21/16 12:14 PMETF’s with exposure to Spectrum Pharmaceuticals, Inc. : June 21, 2016 -
06/21/16 10:43 AMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Stock Momentum Hits Weakness - CML News
06/14/16 06:11 PMCan Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Surprise Analysts this Quarter? - Investor Newswire
06/10/16 09:33 AMNew Market Research Report: Spectrum Pharmaceuticals, Inc. (formerly NeoTherapeutics, Inc.)
06/09/16 05:27 AMBRIEF-Spectrum Pharmaceuticals' unit, Allos Therapeutics and Sandoz enter settlement agreement - * On June 8, 2016, co's unit , Allos Therapeutics and Sandoz Inc entered into a settlement agreement
06/07/16 06:49 PMSPECTRUM PHARMACEUTICALS INC. (NASDAQ:SPPI) Financial Condition Compared to S&P 500 - CML News
06/01/16 09:30 AMStock Review and Earnings Check on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - HNN - Stock Review and Earnings Check on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to report quarterly EPS of $-0.26. The company's next earnings report is expected to be ...and more »
06/01/16 09:30 AMEarnings Analysis to see: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Achillion Pharmaceuticals, Inc. (NASDAQ ... - Beacon Chronicle - Earnings Analysis to see: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Achillion Pharmaceuticals, Inc. (NASDAQ ...Beacon ChronicleLast Trade: The Company closed its last session at $7.49 with the gain of 0.81%. The market capitalization of the company is $519.13 Million, with the average Volume of 854.28K. The stock currently has its 52-Week High range of $7.74 and 52-week low ...and more »
06/01/16 06:33 AMSpectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2016 Healthcare Conference on June 8th - [at noodls] - dd5489f0-e04b-43e7-90bf-3ab7ea7ddd46.pdf June 1, 2016 HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development ...
05/31/16 06:55 PMFloating Price Update: Nektar Therapeutics (NASDAQ:NKTR) , Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Street Updates - Floating Price Update: Nektar Therapeutics (NASDAQ:NKTR) , Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Street UpdatesSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) after beginning at $7.44, closed at $7.43 by cutting down -0.13% in recent trading session. Most recent session's volume of 641.59 thousand shares lower than its average volume of 850.83 thousand shares.and more »
05/29/16 10:16 PMStock Rating Review for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - HNN - Stock Rating Review for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)HNNInvestors may choose to follow the views of professional Wall Street analysts that regularly track the company. Covering equity analysts presently have a consensus stock rating of 1.67 on shares of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI). Covering ...and more »
05/28/16 05:14 PMSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) One-Year Price Target At $9.33 - Investor Newswire - Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) One-Year Price Target At $9.33Investor NewswireFirst Call has set a 52-week price target of $9.33 on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) stock after completion of its survey. For the approaching quarter, EPS estimate is set at $-0.32 and for underway fiscal at $-1.00. This estimate for ...and more »
05/25/16 08:34 AMSPECTRUM PHARMACEUTICALS INC : Other Events (form 8-K) - 05/05 SPECTRUM PHARMACEUTICALS INC: Results of Operations and Financial Condition, Fi.. 05/05 SPECTRUM PHARMACEUTICALS: Reports First Quarter 2016 Financial Results and Pipe.. 05/05 SPECTRUM PHARMACEUTICALS: Reports First Quarter 2016 Financial Results and ...
05/25/16 06:06 AMSPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events -
05/24/16 10:31 PMEarnings Review and Stock Rundown for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) - Wall Street Hints and News - Earnings Review and Stock Rundown for Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Wall Street Hints and NewsEarnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) to post quarterly EPS of $-0.26. The company is expected to next publish earnings on or ...and more »
05/23/16 10:13 AMActive Stocks: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Advanced Micro Devices, Inc. (NASDAQ:AMD), The ... - KC Register - Active Stocks: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Advanced Micro Devices, Inc. (NASDAQ:AMD), The ...KC RegisterSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)'s stock had its “hold” rating reiterated by equities research analysts at Jefferies Group in a note issued to investors on Monday, Analyst Ratings Network.com reports. They presently have a $6.00 target ...and more »

Social

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals logoSpectrum Pharmaceuticals, Inc. is a biotechnology Company. The Company is engaged in commercial and drug development operations with a focus on hematology and oncology. The Company is engaged in acquiring, developing and commercializing the pipeline of late-stage clinical and commercial drug compounds. The Company market five drugs for the treatment of cancer, which includes FUSILEV injection for patients with advanced metastatic colorectal cancer and to counteract certain effects of methotrexate therapy; ZEVALIN injection for patients with follicular non-Hodgkin's lymphoma; FOLOTYN injection for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL); MARQIBO injection for patients with Philadelphia chromosome–negative acute lymphoblastic leukemia, and BELEODAQ injection for patients with relapsed or refractory PTCL.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SPPI
  • CUSIP: 84763A10
Key Metrics:
  • Previous Close: $6.87
  • 50 Day Moving Average: $6.67
  • 200 Day Moving Average: $6.23
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $450.65M
  • Beta: 1.45
  • Current Year EPS Consensus Estimate: $-1.02 EPS
  • Next Year EPS Consensus Estimate: $-0.89 EPS
Additional Links:
Spectrum Pharmaceuticals (NASDAQ:SPPI) Chart for Saturday, July, 30, 2016